ATE85223T1 - Phospholipase-a2-inhibierende zusammensetzungen und ihre anwendung. - Google Patents
Phospholipase-a2-inhibierende zusammensetzungen und ihre anwendung.Info
- Publication number
- ATE85223T1 ATE85223T1 AT88309996T AT88309996T ATE85223T1 AT E85223 T1 ATE85223 T1 AT E85223T1 AT 88309996 T AT88309996 T AT 88309996T AT 88309996 T AT88309996 T AT 88309996T AT E85223 T1 ATE85223 T1 AT E85223T1
- Authority
- AT
- Austria
- Prior art keywords
- cell
- phospholipase
- application
- pla2
- permeable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL8425287A IL84252A (en) | 1987-10-23 | 1987-10-23 | Phospholipase inhibiting compositions |
| EP88309996A EP0315349B1 (de) | 1987-10-23 | 1988-10-24 | Phospholipase-A2-inhibierende Zusammensetzungen und ihre Anwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE85223T1 true ATE85223T1 (de) | 1993-02-15 |
Family
ID=11058262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88309996T ATE85223T1 (de) | 1987-10-23 | 1988-10-24 | Phospholipase-a2-inhibierende zusammensetzungen und ihre anwendung. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5064817A (de) |
| EP (1) | EP0315349B1 (de) |
| JP (1) | JPH0270703A (de) |
| AT (1) | ATE85223T1 (de) |
| CA (1) | CA1327936C (de) |
| DE (1) | DE3878157T2 (de) |
| ES (1) | ES2053757T3 (de) |
| IL (1) | IL84252A (de) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5925375A (en) * | 1987-05-22 | 1999-07-20 | The Liposome Company, Inc. | Therapeutic use of multilamellar liposomal prostaglandin formulations |
| GB9122051D0 (en) * | 1991-10-17 | 1991-11-27 | Univ Nottingham | Medicines |
| ES2044781B1 (es) * | 1992-04-14 | 1994-10-01 | Menarini Lab | Procedimiento para la preparacion de nuevas amidas con accion inhibidora de la fosfolipasa a2 |
| GB2270920B (en) * | 1992-09-25 | 1997-04-02 | Univ Keele | Alginate-bioactive agent conjugates |
| US5981252A (en) * | 1993-06-25 | 1999-11-09 | Smithkline Beecham | Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| US6682913B1 (en) | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
| JP2001131132A (ja) * | 1999-08-26 | 2001-05-15 | Kawaken Fine Chem Co Ltd | 新規な脂肪酸アルカノールアミド化合物及びそれを含有する界面活性剤組成物 |
| US6420487B1 (en) * | 1999-09-08 | 2002-07-16 | Council Of Scientific And Industrial Research | Process for the preparation of thermoprecipitating affinity polymers |
| US7608598B2 (en) | 2000-01-10 | 2009-10-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of conjunctivitis |
| US8916539B2 (en) * | 2000-01-10 | 2014-12-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of disease |
| US7504384B2 (en) * | 2000-01-10 | 2009-03-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of infection |
| US9040078B2 (en) * | 2000-01-10 | 2015-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases of the nervous system |
| US7772196B2 (en) * | 2000-01-10 | 2010-08-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| US8076312B2 (en) * | 2000-01-10 | 2011-12-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Use of lipid conjugates in the treatment of disease |
| US8501701B2 (en) * | 2000-01-10 | 2013-08-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Use of lipid conjugates in the treatment of disease |
| US7101859B2 (en) * | 2000-01-10 | 2006-09-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| US7893226B2 (en) | 2004-09-29 | 2011-02-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
| WO2001051003A2 (en) * | 2000-01-10 | 2001-07-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of disease |
| US20090325876A1 (en) * | 2004-09-29 | 2009-12-31 | Saul Yedgar | Use of lipid conjugates in the treatment of diseases associated with vasculature |
| US7811999B2 (en) * | 2000-01-10 | 2010-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
| US8304395B2 (en) * | 2000-01-10 | 2012-11-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Lipid conjugates in the treatment of disease |
| US7141552B2 (en) * | 2000-01-10 | 2006-11-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| US7393938B2 (en) * | 2000-01-10 | 2008-07-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| TWI281407B (en) | 2000-09-18 | 2007-05-21 | Vasogen Ireland Ltd | Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| CA2319928A1 (en) | 2000-09-18 | 2002-03-18 | Vasogen Ireland Limited | Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
| US7390795B2 (en) * | 2000-12-18 | 2008-06-24 | Pentraxin Therapeutics Limited | Treatment and prevention of tissue damage |
| US8883761B2 (en) * | 2001-01-10 | 2014-11-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases associated with vasculature |
| GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| DE10112825A1 (de) | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
| JP2002301352A (ja) * | 2001-04-09 | 2002-10-15 | Kawaken Fine Chem Co Ltd | １，３−プロパンジオール誘導体含有乳化剤及びそれを含有する乳化組成物 |
| DE10209821A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
| DE10209822A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
| US6923961B2 (en) * | 2002-04-30 | 2005-08-02 | Fziomed, Inc. | Chemically activated carboxypolysaccharides and methods for use to inhibit adhesion formation and promote hemostasis |
| GB0211136D0 (en) | 2002-05-15 | 2002-06-26 | Univ London | Treatment and prevention of tissue damage |
| IL166506A0 (en) | 2002-09-11 | 2006-01-15 | Fresenius Kabi De Gmbh | Hasylated polypeptides especially hasylated erythropoietin |
| ES2314238T3 (es) | 2002-10-08 | 2009-03-16 | Fresenius Kabi Deutschland Gmbh | Conjugados de oligosacaridos farmaceuticamente activos. |
| BR0301513A (pt) * | 2003-05-16 | 2005-03-15 | Fundacao De Amparo A Pesquisa | Lipossomos, formulações lipossÈmicas, seus usos e processos de obtenção, processo para a produção de soro hiperimune e método de tratamento profilático ou curativo de doenças ou distúrbios passìveis de serem tratados pela administração de soro hiperimune |
| WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| JP4511470B2 (ja) | 2003-10-29 | 2010-07-28 | 帝人株式会社 | ヒアルロン酸化合物、そのハイドロゲルおよび関節軟骨損傷治療用材料 |
| CN101659704A (zh) | 2004-03-11 | 2010-03-03 | 弗雷泽纽斯卡比德国有限公司 | 通过还原氨基化制备的羟烷基淀粉和蛋白质的偶联物 |
| US20050244367A1 (en) * | 2004-05-03 | 2005-11-03 | Ilypsa, Inc. | Phospholipase inhibitors localized in the gastrointestinal lumen |
| AU2005305456B2 (en) * | 2004-11-17 | 2011-05-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of disease |
| US7808904B2 (en) * | 2004-11-18 | 2010-10-05 | Fortinet, Inc. | Method and apparatus for managing subscriber profiles |
| CA2617484A1 (en) | 2005-08-03 | 2007-02-15 | Morria Biopharmaceuticals | Use of lipid conjugates in cystic fibrosis and applications thereof |
| AU2006276435B2 (en) * | 2005-08-04 | 2011-10-13 | Teijin Limited | Cellulose derivative |
| JP4744973B2 (ja) * | 2005-08-05 | 2011-08-10 | 株式会社トプコン | 眼底カメラ |
| AU2006292892B2 (en) | 2005-09-21 | 2011-10-27 | Kode Biotech Limited | Cell surface coating with hyaluronic acid oligomer derivative |
| MX2008005666A (es) | 2005-11-03 | 2009-03-02 | Ilypsa Inc | Compuestos multivalentes de indol y uso de los mismos como inhibidores de fosfolipasa-a2. |
| US8906882B2 (en) | 2005-11-17 | 2014-12-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Lipid conjugates in the treatment of allergic rhinitis |
| US20110130555A1 (en) * | 2009-05-11 | 2011-06-02 | Saul Yedgar | Lipid-polymer conjugates, their preparation and uses thereof |
| US8859524B2 (en) | 2005-11-17 | 2014-10-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Lipid conjugates in the treatment of chronic rhinosinusitis |
| US20080183282A1 (en) * | 2006-03-09 | 2008-07-31 | Saul Yedgar | Use of lipid conjugates for the coating of stents and catheters |
| US8685430B1 (en) | 2006-07-14 | 2014-04-01 | Abbott Cardiovascular Systems Inc. | Tailored aliphatic polyesters for stent coatings |
| CA2705785A1 (en) * | 2006-11-14 | 2008-05-22 | Saul Yedgar | Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| WO2008059502A2 (en) * | 2006-11-14 | 2008-05-22 | Yissum Research Development Company | Contact lens compositions |
| US7713541B1 (en) | 2006-11-21 | 2010-05-11 | Abbott Cardiovascular Systems Inc. | Zwitterionic terpolymers, method of making and use on medical devices |
| US8455001B2 (en) * | 2007-02-06 | 2013-06-04 | Teijin Limited | Cellulose derivative and method for production thereof |
| JP5242921B2 (ja) * | 2007-02-06 | 2013-07-24 | 帝人株式会社 | ホスファチジルエタノールアミン結合多糖類の製造方法 |
| EP1992364A1 (de) * | 2007-05-16 | 2008-11-19 | Biosuma S.r.l. | Phosphierte oder bisphosphonierte und optional vernetzte Derivate carboxylierter Polysaccharide sowie ihre Herstellung und ihre biomedizinischen Verwendungen |
| EP2070950A1 (de) | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkylstärkederivate und deren Herstellungsverfahren |
| JP2011099029A (ja) * | 2009-11-05 | 2011-05-19 | Teijin Ltd | 多糖類誘導体 |
| WO2015133559A1 (ja) * | 2014-03-06 | 2015-09-11 | 国立大学法人北海道大学 | スフィンゴシン１リン酸により修飾されたヒアルロン酸 |
| CN116585306A (zh) * | 2016-04-29 | 2023-08-15 | 奥菲瑞克斯股份有限公司 | 用于立即治疗膜翅目注毒和其他因组胺释放引起的病症的pla2抑制剂 |
| CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2247163A1 (de) * | 1972-09-26 | 1974-03-28 | Merck Patent Gmbh | Traegermatrix zur fixierung biologisch wirksamer stoffe und verfahren zu ihrer herstellung |
-
1987
- 1987-10-23 IL IL8425287A patent/IL84252A/xx not_active IP Right Cessation
-
1988
- 1988-10-21 US US07/260,588 patent/US5064817A/en not_active Expired - Lifetime
- 1988-10-21 CA CA000581003A patent/CA1327936C/en not_active Expired - Fee Related
- 1988-10-21 JP JP63267013A patent/JPH0270703A/ja active Pending
- 1988-10-24 DE DE8888309996T patent/DE3878157T2/de not_active Expired - Lifetime
- 1988-10-24 AT AT88309996T patent/ATE85223T1/de not_active IP Right Cessation
- 1988-10-24 ES ES88309996T patent/ES2053757T3/es not_active Expired - Lifetime
- 1988-10-24 EP EP88309996A patent/EP0315349B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL84252A0 (en) | 1988-03-31 |
| JPH0270703A (ja) | 1990-03-09 |
| EP0315349A1 (de) | 1989-05-10 |
| DE3878157D1 (de) | 1993-03-18 |
| EP0315349B1 (de) | 1993-02-03 |
| IL84252A (en) | 1994-02-27 |
| US5064817A (en) | 1991-11-12 |
| DE3878157T2 (de) | 1993-05-27 |
| ES2053757T3 (es) | 1994-08-01 |
| CA1327936C (en) | 1994-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE85223T1 (de) | Phospholipase-a2-inhibierende zusammensetzungen und ihre anwendung. | |
| TR200000482T2 (tr) | N-Aroilfenilalanin türevleri. | |
| DE69434181D1 (de) | Therapeutische Peptid Derivate | |
| TR199700844T1 (xx) | Pirazolil-Benzoil T�revleri. | |
| TR199901471T2 (xx) | Pestisidal 1-aril ve piridilpirazol t�revleri. | |
| ES2186300T3 (es) | Oligopeptidos con actividad fungicida. | |
| ES2080739T3 (es) | Nitro-compuestos insecticidamente activos. | |
| ATE108330T1 (de) | Hypotensive okulare mittel. | |
| SE8401135L (sv) | Forfarande for framstellning av iso-cyklosporin d | |
| HK31096A (en) | Unique antigenic epitopes on ige-bearing b lymphocytes | |
| ATE133200T1 (de) | Modifiziertes, biologisch aktives protein | |
| AR241526A1 (es) | N-(1'-metil-2' -metoxietil)-n-cloracetil-2-etil-6-me- tilanilina opticamente activa en calidad de herbicida, pro-cedimiento para su preparacion y composicion herbicida que la contiene. | |
| ATE69050T1 (de) | Organische verbindungen und ihre pharmazeutische verwendung. | |
| ATE108801T1 (de) | Antikoagulierende peptid-alkohole. | |
| AP8800109A0 (en) | "Heterocyclic insecticides". | |
| TR199801902A2 (xx) | S�lfonamid ile s�bstit�e edilmi� kromanlar, bunlar� i�eren farmakolojik bile�imler. | |
| TR199701712T1 (xx) | 1-Amino-3-Benzilurasil'ler | |
| TR200003203T2 (tr) | Karboksaldehitin saflaştırılması | |
| TR199901535A2 (en) | Siklooksigenaz �nleyicisi. | |
| TR200100159T2 (tr) | Antitrombotik maddeler olarak bispiperidinler | |
| FI853708A0 (fi) | Svaorantaendlig, biologiskt soenderfallande funktionell vaetska. | |
| ATE94168T1 (de) | Peptide. | |
| ATE26709T1 (de) | Sparsomycin(sc-rs)-derivate; pharmazeutische zusammensetzung mit antitumorwirkung. | |
| ES2125849T3 (es) | 1-dimetilcarbamoil-3-sustituido-5-sustituido-1h-1,2,4-triazoles. | |
| SU1455625A1 (ru) | 1-(1,3-диметилксантинил-8-тио)-3-морфолинопропанол-2, проявляющий гипотензивную и противоаритмическую активность |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |